Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Colorectal Cancer Screening Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Colorectal cancer screening tests are carried to monitor bowel health of at-risk individuals, typically the elderly, in order to be able to detect and treat colorectal cancer in a timely manner.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Colorectal Cancer Screening Tests under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Colorectal Cancer Screening Tests and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Colorectal Cancer Screening Tests under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Colorectal Cancer Screening Tests Overview
3 Products under Development
3.1 Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
3.2 Colorectal Cancer Screening Tests - Pipeline Products by Segment
3.3 Colorectal Cancer Screening Tests - Pipeline Products by Territory
3.4 Colorectal Cancer Screening Tests - Pipeline Products by Regulatory Path
3.5 Colorectal Cancer Screening Tests - Pipeline Products by Estimated Approval Date
3.6 Colorectal Cancer Screening Tests - Ongoing Clinical Trials
4 Colorectal Cancer Screening Tests - Pipeline Products under Development by Companies
4.1 Colorectal Cancer Screening Tests Companies - Pipeline Products by Stage of Development
4.2 Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
5 Colorectal Cancer Screening Tests Companies and Product Overview
6 Colorectal Cancer Screening Tests- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
List of Tables
Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
Colorectal Cancer Screening Tests - Pipeline Products by Segment
Colorectal Cancer Screening Tests - Pipeline Products by Territory
Colorectal Cancer Screening Tests - Pipeline Products by Regulatory Path
Colorectal Cancer Screening Tests - Pipeline Products by Estimated Approval Date
Colorectal Cancer Screening Tests - Ongoing Clinical Trials
Colorectal Cancer Screening Tests Companies - Pipeline Products by Stage of Development
Colorectal Cancer Screening Tests - Pipeline Products by Stage of Development
Next-Generation Colorectal Cancer Test - Prospective, Multi-center Observational Study for the Clinical Validation of the Next Generation Test for Blood-based Screening of Colorectal Cancer
Circulating Tumor DNA Test - Colorectal Cancer - CORRECT-MRD I: First Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease
Circulating Tumor DNA Test - Colorectal Cancer - CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease
Next Generation AA/CRC Screening Test - Clinical Performance of the Mainz Biomed Colorectal Cancer Screening Test for the Detection of Colorectal Cancer and Advanced Adenoma in an Average Risk Population
Next Generation AA/CRC Screening Test - Validity and Diagnostic Performance of an Optimized Multi-target Stool Nucleic Acid Test Combined with FIT (Mainz Biomed Colorectal Cancer Screening Test) for Early Detection of Colorectal Cancer and Advanced Precancerous Lesions in Colon